Greater Southern California Node of the Clinical Trials Network

临床试验网络大南加州节点

• 批准号: 10173176
• 负责人: YIH-ING HSER
• 金额: $ 12.09万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-06-01 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10173176
• 关键词: 2019-nCoV; Administrative Supplement; Alcohol or Other Drugs use; Attitude; COVID-19; COVID-19 pandemic; California; Caring; Clinic; Clinical Trials Network; Collection; Communities; Community Health; Data; Data Analyses; Data Collection; Development; Electronic Health Record; Epidemic; Evolution; Feasibility Studies; Focus Groups; Funding; Future; Goals; Health; Health Personnel; Health Services Accessibility; Health Status; Healthcare; Healthcare Systems; Idaho; Individual; Interview; Investigation; Knowledge; Licensing; Maine; Measures; Modeling; Opiate Addiction; Opioid; Parents; Participant; Patient Self-Report; Patients; Perception; Periodicity; Pharmaceutical Preparations; Phase; Primary Health Care; Provider; Public Health; Regulation; Reporting; Research; Rural; Rural Community; Scanning; Sea; Services; Shapes; Site; Structure; Surveys; Symptoms; System; Technology; Telemedicine; Telephone; Time; TimeLine; Travel; Treatment outcome; Trust; Uncertainty; Vendor; Videoconferencing; Washington; barrier to care; coronavirus disease; improved; interest; opioid use disorder; pandemic disease; parent project; patient health information; patient population; pragmatic trial; primary care setting; recruit; remote health care; response; service delivery

Project Summary/Abstract This application, responding to the Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047), requests an administrative supplement to the Rural Expansion of Medication Treatment for Opioid Use Disorder (Rural MOUD, CTN-0102). The main purpose of the parent project is to investigate the impact of telemedicine (TM) on MOUD access and retention for individuals with OUD in rural primary care settings. The coronavirus disease 2019 (COVID-19, or COVID for short) pandemic has forced many health care systems to rapidly implement remote care models, which is of direct relevance to this project. Building upon the existing research plan, we request an administrative supplement to conduct a thorough investigation of COVID’s impact on TM practices and access to MOUD in rural communities. In addition to characterizing changes in attitudes and perceptions regarding TM for OUD treatment, we will investigate and assess the impact of COVID over the next 2 years with regard to changes in MOUD access and services (especially TM) in rural primary care settings and in OUD patients’ use of substances (particularly opioids) and health conditions. Study specific aims include: Aim 1. To assess changes in MOUD access and services (especially TM) in rural primary care settings over the COVID pandemic, and Aim 2. To assess changes in OUD patients’ substance use (particularly opioids) and health conditions over the COVID pandemic. The supplement funding will support (1) qualitative data collection and analysis that includes focus groups and semi-structured interviews to document COVID impact from the perspective of community stakeholders, providers, and patients drawn from primary care clinics serving rural communities, and (2) quantitative data collection and analysis that includes health records for patients served by the rural primary care clinics as well as self-report from OUD patients’ participant surveys to investigate COVID impact on the use of healthcare, TM, and substances. Findings will contribute to scientific knowledge regarding COVID impact, responses, and consequences in rural communities, as well as to inform and shape future development of remote care models.

项目总结/文摘